Buchumschlag

Single‐cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Tina Bagratuni, Foteini Aktypi, Ourania Theologi, Maria Sakkou, Kleio Maria Verrou, Nefeli Mavrianou‐Koutsoukou, Dimitrios Patseas, Christine Liacos, Stamatia Skourti, Alexandra Papadimou, Kostantina Taouxi, Foteini Theodorakakou, Georgios Kollias, Petros Sfikakis, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	HemaSphere
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma
von: Maria Papatsirou, et al.
Veröffentlicht: (2024)

Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma
von: Maria Frantzi, et al.
Veröffentlicht: (2026)

Repurposing pacritinib to target MYD88 ‐mutated Waldenström macroglobulinaemia
von: Shirong Liu, et al.
Veröffentlicht: (2025)

PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation
von: Marcello Viscovo, et al.
Veröffentlicht: (2024)

MYD88‐mutated Lymphoplasmacytic Lymphoma With Monoclonal Immunoglobulin G: A Case Report
von: Morten Yung Isaksen, et al.
Veröffentlicht: (2025)

Schnitzler Syndrome as an Autoinflammatory Disease Driven by B‐Cell‐Specific Somatic MYD88 Mutation
von: Yuyi Zhou, et al.
Veröffentlicht: (2026)

Cutaneous Involvement of Waldenström Macroglobulinemia With MYD88 L265P Mutation Identified in Lesional Skin
von: Chika Shibuya, et al.
Veröffentlicht: (2026)

Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma
von: Evangelos Terpos, et al.
Veröffentlicht: (2024)

Frequency and Relevance of MYD88L256P Mutation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy
von: Alexandre Guérémy, et al.
Veröffentlicht: (2025)

ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells
von: M. Munshi, et al.
Veröffentlicht: (2024)

Detection of MYD88 L265P Mutation by Allele‐Specific Polymerase Chain Reaction in Atypical Lymphoplasmacytic Lymphoma
von: Ja Young Lee, et al.
Veröffentlicht: (2025)

Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
von: Shirong Liu, et al.
Veröffentlicht: (2025)

Xuming Zhusan Decoction Attenuates Post‐Stroke via Modulating TLR4 / MYD88 / NF ‐ κB Pathway in Mice
von: Xi Liu, et al.
Veröffentlicht: (2026)

Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B‐cell lymphoma
von: Tomotaka Suzuki, et al.
Veröffentlicht: (2025)

Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First‐Line Treatment
von: Polyxeni Spiliopoulou, et al.
Veröffentlicht: (2025)

Rapid and Sensitive Detection of the MYD88 L265P Mutation for Lymphoplasmocytic Lymphoma/Waldenström's Macroglobulinemia via CRISPR‐Cas12a
von: Rumei Sun, et al.
Veröffentlicht: (2025)

Coreopsis Tinctoria Nutt . Polyphenols Protect Intestinal Barrier in Depressed Mice by Modulating TLR4/MYD88/NF‐κB Pathway
von: Zhen Wang, et al.
Veröffentlicht: (2026)

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB Pathway
von: Jiayu Wang, et al.
Veröffentlicht: (2025)

Thrombotic and bleeding complications in patients with AL amyloidosis
von: Despina Fotiou, et al.
Veröffentlicht: (2024)

Synovial expression of glucocorticoid receptor parallels fibroblast activation in patients with rheumatoid arthritis
von: Nikolaos I. Vlachogiannis, et al.
Veröffentlicht: (2024)

644 | EFFICACY OF ZANUBRUTINIB IN NEWLY DIAGNOSED MYD88‐MUTATED DIFFUSE LARGE B‐CELL LYMPHOMA: A RETROSPECTIVE SINGLE‐CENTER REAL‐WORLD STUDY
von: W. Huang, et al.
Veröffentlicht: (2025)

Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic Regimens
von: Foteini Paradeisi, et al.
Veröffentlicht: (2025)

170 | ROLE OF NON‐CODING RNAs AND DNA METHYLATION IN REGULATING INTRACELLULAR SIGNALING AND CYTOKINE PATHWAYS IN MYD88WT WALDENSTRÖM MACROGLOBULINEMIA: A MULTI‐OMIC ANALYSIS
von: K. L. Chohan, et al.
Veröffentlicht: (2025)

Chapter «Odyssey» Scientific Debate: Rhetoric and STEM Education
von: Egglezou, Foteini
Veröffentlicht: (2022)

Homeland–diaspora nexus during crisis: Towards a transformed engagement model
von: Foteini Kalantzi
Veröffentlicht: (2024)

Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials
von: Ioannis Ntanasis‐Stathopoulos, et al.
Veröffentlicht: (2025)

Multitemporal analysis of the flow of sediments using modis MYD09 and MOD09 images
von: Iván Darío Carrillo Durán
Veröffentlicht: (2019)

Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways
von: Alaa Abouelhamd, et al.
Veröffentlicht: (2025)

Evaluation of MYD88 p. L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B‐cell lymphoma of the central nervous system
von: Vincent Harlay, et al.
Veröffentlicht: (2025)

Determinants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution
von: Meletios A. Dimopoulos, et al.
Veröffentlicht: (2025)

Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre
von: Maria Gavriatopoulou, et al.
Veröffentlicht: (2026)

Erratum: Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/Ho‐1/Nrf2 Pathways
Veröffentlicht: (2025)

Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis
von: Foteini Theodorakakou, et al.
Veröffentlicht: (2025)

Insights from leptohadronic modelling of the brightest blazar flare
von: Podlesnyi, Egor, et al.
Veröffentlicht: (2025)

Search for neutrino emission from blazar $γ$-ray flares accounting for possible neutrino time delays
von: Podlesnyi, Egor, et al.
Veröffentlicht: (2025)

Evaluation of Patient Satisfaction With Hospital Foodservice During Treatment at a General Hospital in Mainland Greece
von: Foteini Potsi, et al.
Veröffentlicht: (2025)

Europeanization and Health Policy in the European Union During Covid‐19 Pandemic: The Case of Greece
von: Georgios Maris, et al.
Veröffentlicht: (2026)

Response to “Determinants of Ultra‐Long‐Term Survival in Multiple Myeloma: A Critical Appraisal of Foundational Assumptions and a Call for Biologically Driven Inquiry”
von: Meletios A. Dimopoulos, et al.
Veröffentlicht: (2026)

Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients
von: Maria Papatsirou, et al.
Veröffentlicht: (2024)

Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA
von: Evangelos Terpos, et al.
Veröffentlicht: (2024)